Home > Boards > US OTC > Delisted > BioPharm Asia, Inc (fka BFAR)

Thanks for the reply. The extreme volatility from

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
hercules16 Member Profile
 
Followed By 0
Posts 88
Boards Moderated 0
Alias Born 09/12/01
160x600 placeholder
Snowflake Raises Fiscal Year Product Revenue Guidance
Snowflake Inc. raised its product revenue projections for the year, following a stronger-than-expected performance in the third quarter.
Snowflake's 3Q Revenue More Than Doubles, Net Loss Narrows
Hewlett Packard Enterprise to Build New Supercomputer for U.S. Energy Dept.
Soybeans Rise as Vegetable Oil Strength Seen Ahead -- Daily Grain Highlights
Front Month Nymex RBOB Gasoline Rose 0.57% to Settle at $1.9511 -- Data Talk
Front Month Nymex Natural Gas Fell 6.77% to Settle at $4.2580 -- Data Talk
Top Company News of the Day
Amgen Says FDA Approves Kyprolis Combination to Treat Multiple Myeloma
EURO STOXX 50 Index Ends 2.86% Higher at 4179.15 -- Data Talk
STOXX Europe 600 Index Ends 1.71% Higher at 470.86 -- Data Talk
FTSE 100 Index Ends 1.55% Higher at 7168.68 -- Data Talk
DAX Ends 2.47% Higher at 15472.67 -- Data Talk
CAC 40 Index Ends 2.39% Higher at 6881.87 -- Data Talk
STOXX Europe 50 Index Ends 2.03% Higher at 3666.37 -- Data Talk
FTSE Closes Up on Comments Suggesting New Covid-19 Variant Is Less Severe Than First Seen
GM, Posco JV Will Produce Battery Materials
Vertex Pharmaceuticals Up Over 7%, Best Performer in The S&P 500 and Nasdaq 100 So Far Today -- Data Talk
CTI BioPharma Shares Slide as FDA Extends Pacritinib Review
U.S. Ethanol Inventories Turn Higher
U.S. Oil Inventories Decline, Production Rises
BeyondSpring Shares Plummet After FDA Rejects Plinabulin
U.S. Factory Activity Expanded Strongly in November; Supply-Chain Strains Eased Modestly -- ISM
Salesforce.com On Pace for Largest Percent Decrease in Nearly a Year -- Data Talk
U.S. Manufacturing Sector Kept Momentum in November -- IHS Markit
ITA Airways Firms Up Order for 28 Airbus Aircraft
Unemployment Rate Seen Ticking Down Again -- Data Week Ahead
Correction to Greece Covid-19 Article on Nov. 30
Federal Reserve to Look at Speeding Up Cuts to Asset Purchases; Richard Cordray a Candidate for Fed's Top Banking Regulator
Groupon Appoints Kedar Deshpande as New CEO
ADP Names Maria Black President, John Ayala Chief Operating Officer
hercules16   Saturday, 03/05/11 07:27:52 PM
Re: value1008 post# 153
Post # of 7742 
Thanks for the reply. The extreme volatility from overvalued to undervalued is not neccessarily a bad thing, in that allows for the potential to generate trading gains (Congratulations for your trades last year, I also had some nice gains last year selling at $4 and $5). I think BFAR gets especially beat up as it is a long wait between 3rd quarter earnings and 4th quarter earnings and people are too impatient, and it is too illiquid to be suitable for the vast majority of institutions.

I've bought unloved issues before (e.g. - SFI 2 years ago) and the subsequent gains can be significant. (Edit KCAP probabaly would have been a better exapmple for my moniker here; Not quite as impresive as SFI but very nice returns nonetheless about 350% return in 2 years exculding dividends). No guarentees here of course. I also like CCME, TSTC, GFRE, CHBT.

Best Regards,
hercules

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences